Emily Field
Stock Analyst at Barclays
(3.18)
# 2,520
Out of 4,478 analysts
822
Total ratings
46.2%
Success rate
2.2%
Average return
Main Sectors:
Stocks Rated by Emily Field
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Maintained: Buy | $1,400 | $1,200.06 | +16.66% | 18 | Jun 29, 2026 | |
| MRK Merck & Co. | Maintained: Buy | $140 | $126.78 | +10.43% | 9 | Jun 26, 2026 | |
| ABBV AbbVie | Maintained: Buy | $275 | $254.76 | +7.94% | 9 | Jun 26, 2026 | |
| PFE Pfizer | Maintained: Sell | $25 | $23.72 | +5.40% | 5 | Jun 15, 2026 | |
| BMY Bristol-Myers Squibb Company | Maintained: Buy | $75 | $56.70 | +32.28% | 6 | Jun 2, 2026 | |
| BIIB Biogen | Reiterated: Hold | $185 | $208.46 | -11.25% | 5 | May 14, 2026 | |
| AMGN Amgen | Maintained: Hold | $350 | $366.44 | -4.49% | 6 | May 5, 2026 | |
| GILD Gilead Sciences | Maintained: Hold | $155 | $129.61 | +19.59% | 3 | Apr 21, 2026 | |
| CYTK Cytokinetics | Rated: Buy | $95 | $85.57 | +11.02% | 7 | Apr 6, 2026 | |
| GSK GSK plc | Downgraded: Sell | n/a | $53.09 | - | 1 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $155.49 | - | 1 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $42.61 | - | 1 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $51.61 | - | 1 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 275.00 | $331.80 | -17.12% | 59 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 1,450p | $1,983.00 | -26.88% | 126 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €115.00 → €105.00 | $74.51 | +40.92% | 37 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 46.50 → CHF 55.00 | $70.64 | -22.14% | 9 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | kr 700.00 → kr 375.00 | $321.98 | +16.47% | 54 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 14,000p | $14,100.00 | -0.71% | 78 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €22.00 | $26.40 | -16.67% | 32 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | CHF 90.00 | $125.10 | -28.06% | 44 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €25.00 | $51.18 | n/a | 59 | Jun 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 2,000p | $1,544.00 | n/a | 61 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | kr 2,100 | $1,861.29 | n/a | 45 | Apr 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €195.00 | $142.80 | n/a | 74 | Oct 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €390.00 → €430.00 | $811.30 | n/a | 21 | Jun 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €8.00 → €9.00 | $9.06 | n/a | 4 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €75.00 | $169.50 | n/a | 22 | Nov 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €125.00 → €90.00 | $257.85 | n/a | 14 | Oct 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $143 → $125 | $30.36 | n/a | 7 | Jan 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $52.31 | $18.42 | n/a | 1 | Aug 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $0.00001 | n/a | 1 | Apr 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $33 | $7.17 | n/a | 2 | Jun 1, 2018 |
Eli Lilly and Company
Jun 29, 2026
Maintained: Buy
Price Target: $1,400
Current: $1,200.06
Upside: +16.66%
Merck & Co.
Jun 26, 2026
Maintained: Buy
Price Target: $140
Current: $126.78
Upside: +10.43%
AbbVie
Jun 26, 2026
Maintained: Buy
Price Target: $275
Current: $254.76
Upside: +7.94%
Pfizer
Jun 15, 2026
Maintained: Sell
Price Target: $25
Current: $23.72
Upside: +5.40%
Bristol-Myers Squibb Company
Jun 2, 2026
Maintained: Buy
Price Target: $75
Current: $56.70
Upside: +32.28%
Biogen
May 14, 2026
Reiterated: Hold
Price Target: $185
Current: $208.46
Upside: -11.25%
Amgen
May 5, 2026
Maintained: Hold
Price Target: $350
Current: $366.44
Upside: -4.49%
Gilead Sciences
Apr 21, 2026
Maintained: Hold
Price Target: $155
Current: $129.61
Upside: +19.59%
Cytokinetics
Apr 6, 2026
Rated: Buy
Price Target: $95
Current: $85.57
Upside: +11.02%
GSK plc
Jan 6, 2026
Downgraded: Sell
Price Target: n/a
Current: $53.09
Upside: -
Jan 6, 2026
Upgraded: Hold
Price Target: n/a
Current: $155.49
Upside: -
Jan 6, 2026
Downgraded: Hold
Price Target: n/a
Current: $42.61
Upside: -
Jan 6, 2026
Upgraded: Buy
Price Target: n/a
Current: $51.61
Upside: -
Sep 24, 2025
Maintained: Hold
Price Target: CHF 275.00
Current: $331.80
Upside: -17.12%
Aug 12, 2025
Maintained: Hold
Price Target: 1,450p
Current: $1,983.00
Upside: -26.88%
Aug 12, 2025
Maintained: Buy
Price Target: €115.00 → €105.00
Current: $74.51
Upside: +40.92%
Aug 8, 2025
Maintained: Buy
Price Target: CHF 46.50 → CHF 55.00
Current: $70.64
Upside: -22.14%
Aug 4, 2025
Maintained: Hold
Price Target: kr 700.00 → kr 375.00
Current: $321.98
Upside: +16.47%
Jul 30, 2025
Maintained: Buy
Price Target: 14,000p
Current: $14,100.00
Upside: -0.71%
Jul 29, 2025
Maintained: Sell
Price Target: €22.00
Current: $26.40
Upside: -16.67%
Jul 21, 2025
Maintained: Sell
Price Target: CHF 90.00
Current: $125.10
Upside: -28.06%
Jun 27, 2025
Maintained: Hold
Price Target: €25.00
Current: $51.18
Upside: n/a
Apr 25, 2025
Maintained: Hold
Price Target: 2,000p
Current: $1,544.00
Upside: n/a
Apr 15, 2025
Maintained: Buy
Price Target: kr 2,100
Current: $1,861.29
Upside: n/a
Oct 29, 2024
Maintained: Buy
Price Target: €195.00
Current: $142.80
Upside: n/a
Jun 21, 2023
Maintained: Buy
Price Target: €390.00 → €430.00
Current: $811.30
Upside: n/a
Nov 21, 2022
Maintained: Sell
Price Target: €8.00 → €9.00
Current: $9.06
Upside: n/a
Nov 25, 2021
Maintained: Sell
Price Target: €75.00
Current: $169.50
Upside: n/a
Oct 15, 2021
Downgraded: Hold
Price Target: €125.00 → €90.00
Current: $257.85
Upside: n/a
Jan 19, 2021
Maintained: Hold
Price Target: $143 → $125
Current: $30.36
Upside: n/a
Aug 28, 2020
Maintained: Hold
Price Target: $52.31
Current: $18.42
Upside: n/a
Apr 25, 2019
Maintained: Buy
Price Target: $14
Current: $0.00001
Upside: n/a
Jun 1, 2018
Initiated Coverage: Buy
Price Target: $33
Current: $7.17
Upside: n/a